CompuFlo Thoracic Epidural Study
Traditional Loss-of-resistance Technique vs Compuflo-aided Technology for Placement of a Thoracic Epidural Catheter: a Randomized Trial of the Effect on the Success Rate
1 other identifier
interventional
120
1 country
1
Brief Summary
Traditionally, loss-of-resistance (LOR) to air or saline with a special ground-glass syringe is the technique used to identify epidural space, but failure rates up to 30% have been reported using this technique for thoracic epidural placement. This failure rate has sparked the search for newer techniques to improve the success rate for placement.The CompuFlo epidural system is a device that provides anesthesiologists and other healthcare providers the ability to quantitatively determine and document the pressure at the needle tip in real time. The device's proprietary dynamic pressure sensing technology (DPS) allows it to provide objective visual and audible in-tissue pressure feedback that allows anesthesiologists to identify the epidural space. The purpose this research study is to compare the success rate of the two different approaches (traditional method v/s CompuFlo assisted) to thoracic epidural placement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 22, 2019
CompletedFirst Posted
Study publicly available on registry
February 1, 2019
CompletedStudy Start
First participant enrolled
March 26, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2022
CompletedResults Posted
Study results publicly available
October 19, 2022
CompletedOctober 19, 2022
August 1, 2022
2.8 years
January 22, 2019
July 25, 2022
September 26, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants With Successful Thoracic Epidural Catheter Placement
Successful placement of thoracic epidural analgesia will be determined by the loss of cold sensation on the chest or abdomen depending on the site of epidural placement using a dermatome bilaterally. Subjects will be tested at 10 minute intervals.
Maximum 20 minutes post administration of epidural test dose
Secondary Outcomes (7)
Amount of Time Required to Complete the Procedure
During procedure, assessed up to 15 minutes
Number of Participants Who Reported Loss of Cold Sensation at Various Time Points
Up to 20 minutes post administration of epidural test dose
Mean Arterial Pressure at Baseline and 20 Minutes Post Procedure
Up to 20 minutes post administration of epidural test dose
Number of Participants With Significant Change in Systolic Blood Pressure
Up to 20 minutes post administration of epidural test dose
Number of Participants Whose Provider Answered "Yes" or "No" to Ease of Catheter Placement
During procedure, assessed up to 15 minutes
- +2 more secondary outcomes
Study Arms (2)
Traditional epidural group
ACTIVE COMPARATORThe traditional approach to placing thoracic epidurals by loss-of-resistance technique using a ground glass syringe will be used in this group.
CompuFlo epidural group
EXPERIMENTALThis device (CompuFlo) will aid in correct placement of the epidural by electronically sensing pressure in real time and by providing a numerical value on a read out screen to determine a loss of resistance. There is also an audio signal that signals a loss of resistance.
Interventions
Thoracic epidurals will be administered using the traditional loss-of resistance technique.
Pressure sensing technology to consistently and accurately identify the thoracic epidural space.
Eligibility Criteria
You may qualify if:
- Age: 18 to 70
- BMI: 18 to 50 kg/m2
- Require pain control for major thoracic or abdominal surgeries
- Require pain control for rib fractures
- English is the subject's first language
- Must be able to signed informed consent
You may not qualify if:
- Age: Less than 18 and older than 70
- Must be free of significant valvular heart disease
- Pregnant women
- Prisoners
- Contraindication to thoracic epidural anesthesia
- Allergy or hypersensitivity to local anesthetics
- Unable to provide written informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Iowa Hospitals and Clinics
Iowa City, Iowa, 52242, United States
Related Publications (7)
Block BM, Liu SS, Rowlingson AJ, Cowan AR, Cowan JA Jr, Wu CL. Efficacy of postoperative epidural analgesia: a meta-analysis. JAMA. 2003 Nov 12;290(18):2455-63. doi: 10.1001/jama.290.18.2455.
PMID: 14612482RESULTCarli F, Mayo N, Klubien K, Schricker T, Trudel J, Belliveau P. Epidural analgesia enhances functional exercise capacity and health-related quality of life after colonic surgery: results of a randomized trial. Anesthesiology. 2002 Sep;97(3):540-9. doi: 10.1097/00000542-200209000-00005.
PMID: 12218518RESULTPopping DM, Elia N, Marret E, Remy C, Tramer MR. Protective effects of epidural analgesia on pulmonary complications after abdominal and thoracic surgery: a meta-analysis. Arch Surg. 2008 Oct;143(10):990-9; discussion 1000. doi: 10.1001/archsurg.143.10.990.
PMID: 18936379RESULTLeurcharusmee P, Arnuntasupakul V, Chora De La Garza D, Vijitpavan A, Ah-Kye S, Saelao A, Tiyaprasertkul W, Finlayson RJ, Tran DQ. Reliability of Waveform Analysis as an Adjunct to Loss of Resistance for Thoracic Epidural Blocks. Reg Anesth Pain Med. 2015 Nov-Dec;40(6):694-7. doi: 10.1097/AAP.0000000000000313.
PMID: 26469364RESULTParra MC, Washburn K, Brown JR, Beach ML, Yeager MP, Barr P, Bonham K, Lamb K, Loftus RW. Fluoroscopic Guidance Increases the Incidence of Thoracic Epidural Catheter Placement Within the Epidural Space: A Randomized Trial. Reg Anesth Pain Med. 2017 Jan/Feb;42(1):17-24. doi: 10.1097/AAP.0000000000000519.
PMID: 27922948RESULTGong Y, Shi H, Wu J, Labu D, Sun J, Zhong H, Li L, Xin X, Wang L, Wu L, Ma D. Pressure waveform-guided epidural catheter placement in comparison to the loss-of-resistance conventional method. J Clin Anesth. 2014 Aug;26(5):395-401. doi: 10.1016/j.jclinane.2014.01.015. Epub 2014 Aug 27.
PMID: 25172504RESULTRanganath YS, Ramanujam V, Al-Hassan Q, Sibenaller Z, Seering MS, Singh TSS, Punia S, Parra MC, Wong CA, Sondekoppam RV. Loss-of-Resistance Versus Dynamic Pressure-Sensing Technology for Successful Placement of Thoracic Epidural Catheters: A Randomized Clinical Trial. Anesth Analg. 2024 Jul 1;139(1):201-210. doi: 10.1213/ANE.0000000000006792. Epub 2024 Jun 17.
PMID: 38190338DERIVED
Results Point of Contact
- Title
- Vice Chair for Research
- Organization
- University of Iowa Hospitals and Clinics
Study Officials
- PRINCIPAL INVESTIGATOR
Yatish S Ranganath, MD
University of Iowa
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Clinical Assistant Professor
Study Record Dates
First Submitted
January 22, 2019
First Posted
February 1, 2019
Study Start
March 26, 2019
Primary Completion
January 1, 2022
Study Completion
June 1, 2022
Last Updated
October 19, 2022
Results First Posted
October 19, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- Individual participant data will be available for sharing immediately after publication and ending 5 years following article publication.
- Access Criteria
- Individual participant data will be accessible to researchers who provide a methodologically sound proposal, to achieve aims in the approved proposal.
All of the individual participant data (IPD) collected during the trial, after deidentification will be shared with researchers who provide a methodologically sound proposal, to achieve aims in the approved proposal. Individual participant data will be available for sharing immediately after publication and ending 5 years following article publication.